Wedbush Downgrades Sionna Therapeutics (SION) to Neutral
Tweet Send to a Friend
Wedbush analyst Laura Chico downgraded Sionna Therapeutics (NASDAQ: SION) from Outperform to Neutral with a price target of $5.00 (from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


